Health Disparities and the Global Landscape of Lymphoma Care Today
- PMID: 28561692
- DOI: 10.1200/EDBK_175444
Health Disparities and the Global Landscape of Lymphoma Care Today
Abstract
Lymphoma encompass a wide variety of distinct disease entities, including, but not limited to, subtypes of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL). In the last 3 decades, therapeutic advancements have resulted in substantial improvements in lymphoma outcome. In most high-income regions, HL is a largely curable disease and for patients with two frequent subtypes of NHL, diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL), survival has dramatically improved with the incorporation of rituximab as a standard treatment approach. Despite these advances, outcomes vary between and across populations. This review will provide updated information about health disparities in lymphoma in the United States and across the globe.
Similar articles
-
Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.Arch Med Res. 2015 Aug;46(6):454-61. doi: 10.1016/j.arcmed.2015.07.004. Epub 2015 Jul 31. Arch Med Res. 2015. PMID: 26235285
-
Transformed follicular non-Hodgkin lymphoma.Blood. 2015 Jan 1;125(1):40-7. doi: 10.1182/blood-2014-04-516815. Epub 2014 Dec 11. Blood. 2015. PMID: 25499449 Review.
-
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.Biol Blood Marrow Transplant. 2015 Nov;21(11):1926-31. doi: 10.1016/j.bbmt.2015.06.007. Epub 2015 Jun 16. Biol Blood Marrow Transplant. 2015. PMID: 26087475
-
[The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type].Prensa Med Argent. 1959 Oct 9;46:2549-54. Prensa Med Argent. 1959. PMID: 14435621 Spanish. No abstract available.
-
[Hodgkin and non-Hodgkin lymphoma of adolescents and young adults].Bull Cancer. 2016 Dec;103(12):1035-1049. doi: 10.1016/j.bulcan.2016.10.011. Epub 2016 Nov 17. Bull Cancer. 2016. PMID: 27866679 Review. French.
Cited by
-
Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial.Int J Hematol. 2018 Apr;107(4):395-404. doi: 10.1007/s12185-018-2403-9. Epub 2018 Jan 22. Int J Hematol. 2018. PMID: 29357080 Review.
-
Increased risk of lymphoid malignancy in patients with herpes zoster: a longitudinal follow-up study using a national cohort.BMC Cancer. 2019 Nov 27;19(1):1148. doi: 10.1186/s12885-019-6349-y. BMC Cancer. 2019. PMID: 31775678 Free PMC article.
-
Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning.Bone Marrow Transplant. 2023 Nov;58(11):1203-1208. doi: 10.1038/s41409-023-02071-8. Epub 2023 Aug 10. Bone Marrow Transplant. 2023. PMID: 37563283 Free PMC article.
-
Follicular lymphoma.Nat Rev Dis Primers. 2019 Dec 12;5(1):83. doi: 10.1038/s41572-019-0132-x. Nat Rev Dis Primers. 2019. PMID: 31831752 Review.
-
Patients' and Clinicians' Perceptions of the Clinical Utility of Predictive Risk Models for Chemotherapy-Related Symptom Management: Qualitative Exploration Using Focus Groups and Interviews.J Med Internet Res. 2024 Jun 20;26:e49309. doi: 10.2196/49309. J Med Internet Res. 2024. PMID: 38901021 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
